Randomized double-blind placebo-controlled trial protocol of Taiqi Peiyuan Wujian Granules in the treatment of acquired immunodeficiency syndrome of Qi and Yin deficiency type

To explore how the method of replenishing qi and nourishing yin can improve the immune function mechanism of HIV/AIDS patients from the perspective of negative immune regulation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400086593

Enrollment

Unknown

Registered

2024-07-06

Start date

2022-03-29

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS.

Interventions

Test group:Taiqi Peiyuan No-fried Granules (15g/time, 2 times/day) +

Control group:Taiqi Peiyuan decoction-free granule simulator (15g/time, 2 times/day) + antiviral treatment.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 65 years old; meet the diagnostic criteria of "AIDS Diagnosis and Treatment Guidelines (2015 Edition) HIV/AIDS"; meet the TCM syndrome differentiation of Qi and Yin deficiency; take initial antiviral treatment (between 3 and 6 months); sign the informed consent form By.

Exclusion criteria

Exclusion criteria: Women who are breastfeeding, pregnant or preparing to become pregnant; those with liver function ALT higher than 1.5 times the upper limit of normal and renal function higher than the upper limit of normal; combined with serious primary diseases such as cardiovascular and cerebrovascular, hematopoietic system; combined with pneumothorax, lung cancer, active Patients with tuberculosis and other serious lung diseases; psychiatric patients; patients with primary immune deficiency, patients with secondary immune deficiency caused by hormones, chemotherapy, etc.

Design outcomes

Primary

Measure	Time frame
Symptoms of traditional Chinese medicine;	—

Secondary

Measure	Time frame
T lymphocyte count;	—

Countries

China

Contacts

Public ContactJianping Ma

Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital.

majianpingm@163.com+86 991 557 2210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026